Particulates of a CRTH2 antagonist

Details for Australian Patent Application No. 2008266853 (hide)

Owner Actimis Pharmaceuticals, Inc.

Inventors Ly, Tai Wei; Li, Hui-Yin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008266853

PCT Pub. Number WO2008/156780

Priority 60/936,972 21.06.07 US

Filing date 18 June 2008

Wipo publication date 24 December 2008

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/156780 Priority application(s): WO2008/156780

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266854-Amine salts of a CRTH2 antagonist

2008266847-Loudness measurement with spectral modifications